A new wave of innovation may reshape how clinicians approach some of the most persistent challenges in patient care. Non-invasive neuromodulation, a technique that uses gentle electrical stimulation ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...

Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...

Boston Scientific’s BSX Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s ...

The growth of the neuromodulation market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on ...

Autonomix Medical, Inc. has announced the issuance of U.S. Patent No. 12,279,889 B2, which supports its mission to develop minimally invasive treatments targeting nerve-related conditions. The patent ...